C
CYTK
Cytokinetics Inc
61.52
+0.79+1.30%After Hours: 60.48 -1.04 -1.69%19:30 10/27 EDT
OPEN/PREV CLOSE60.68/60.73
TODAY RANGE60.47-61.83
VOL1.15M
MARKET CAP8.55B
52 WEEK RANGE57.83-88.31
AVG VOL (3M)1.94M
% TURNOVER0.60%
TURNOVER--
P/E (TTM)-8.5177
% RANGE2.22%
EPS(TTM)-7.2226
P/E(FORWARD)-10.0989
P/B-49.2042
BVPS-1.2503
DIVIDEND--
P/S85.91
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.33B
SHARES OUTSTANDING139.02M
NEXT EARNINGS11/03-11/09
FREE FLOAT135.35M
LOT SIZE1
EX-DATE06/25/2013
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1d ago
Baron Health Care Fund Q3 2026 Top Contributors And Detractors
Simply Wall St·4d ago
Canada Drug Approval Might Change The Case For Investing In Cytokinetics Stock (CYTK)
Seeking Alpha·6d ago
Bristol-Myers Squibb: Why I'm Bullish Ahead Of Q3 Earnings
Dow Jones·10/19 14:32
Cytokinetics Price Target Maintained With a $140.00/Share by HC Wainwright & Co.
Benzinga·10/19 14:22
HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $140 Price Target
TipRanks·10/19 12:35
Cytokinetics price target lowered to $81 from $85 at BofA
TipRanks·10/19 11:40
Cytokinetics announces Health Canada approval of Myqorzo for oHCM treatment
TipRanks·10/17 13:01
Cytokinetics, International Seaways, BJ’s, Grace, PBF Shake-Up
TipRanks·10/16 00:40
Cytokinetics initiated with an Outperform at William Blair
Benzinga·10/15 20:15
Here's How Much $1000 Invested In Cytokinetics 15 Years Ago Would Be Worth Today
Simply Wall St·10/15 19:22
Is Cytokinetics (CYTK) Undervalued As New Aficamten Phase 3 Data Supports Expansion?
Same Industry
Name/Symbol
Change%
Price